Institutional Owners200 (200 N-Q Owners)

Institutional Stock Ownership and Shareholders

CREDIT AGRICOLE (EPA:ACA) has 200 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .

CREDIT AGRICOLE (EPA:ACA) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Important Note!
Note: We do not currently have a CUSIP on file for this security. That means we are unable to search institutional fund filings (13F's) for this company, which means there may be institutional holders that we are unaware of. If you know the CUSIP or would like us to research and update this security, please let us know by leaving a message in the Welcome Group.
File DateFormInvestor Opt Prev
Prev Value
Current Value
2017-11-17 N-Q Lazard Retirement Series Inc (see advisory)
2017-11-29 N-Q Ubs Relationship Funds (see advisory)
2017-09-28 N-Q Mfs Series Trust Ix (see advisory)
2017-11-27 N-Q Ab Variable Products Series Fund, Inc. (see advisory)
2017-11-28 N-Q Active Assets Government Trust (see advisory)
2018-01-29 N-Q Oppenheimer Capital Income Fund (see advisory)
2017-12-29 N-Q Sunamerica Series Trust (see advisory)
2017-12-29 N-Q Oppenheimer Government Cash Reserves (see advisory)
2017-09-29 N-Q John Hancock Investors Trust (see advisory)
2017-10-27 N-Q Western Asset Investment Grade Defined Opportunity Trust Inc. (see advisory)
2018-02-28 N-Q Franklin Templeton Etf Trust (see advisory)
2018-02-28 N-Q Prudential Investment Portfolios, Inc. (see advisory)
2017-09-27 N-Q Commonwealth International Series Trust (see advisory)
2017-09-28 N-Q Fidelity Summer Street Trust (see advisory)
2017-11-28 N-Q Morgan Stanley Variable Investment Series (see advisory)
2017-09-26 N-Q Deutsche Market Trust (see advisory)
2017-11-22 N-Q Thrivent Mutual Funds (see advisory)
2017-09-27 N-Q Blackrock Credit Allocation Income Trust (see advisory)
2018-01-26 N-Q Jpmorgan Trust Iv (see advisory)
2017-11-29 N-Q Prudential Series Fund (see advisory)
2017-09-29 N-Q Two Roads Shared Trust (see advisory)
2018-02-28 N-Q Vanguard Wellesley Income Fund (see advisory)
2018-02-26 N-Q Ab Bond Fund, Inc. (see advisory)
2018-02-27 N-Q Touchstone Strategic Trust (see advisory)
2017-11-24 N-Q Transamerica Series Trust (see advisory)
2017-11-22 N-Q Western Asset Income Fund (see advisory)
2017-09-29 N-Q John Hancock Income Securities Trust (see advisory)
2017-11-27 N-Q John Hancock Variable Insurance Trust (see advisory)
2017-11-22 N-Q Blackrock Strategic Global Bond Fund, Inc. (see advisory)
2018-01-26 N-Q Eaton Vance Tax Advantaged Dividend Income Fund (see advisory)
2017-11-28 N-Q Putnam Variable Trust (see advisory)
2017-09-27 N-Q Funds For Institutions Series (see advisory)
2017-12-22 N-Q Legg Mason Partners Income Trust (see advisory)
2018-03-01 N-Q Sei Institutional Managed Trust (see advisory)
2017-10-26 N-Q Mfs Series Trust X (see advisory)
2017-11-22 N-Q Principal Exchange-traded Funds (see advisory)
2018-01-26 N-Q Jpmorgan Institutional Trust (see advisory)
2017-12-29 N-Q Domini Investment Trust (see advisory)
2017-11-28 N-Q Fidelity Central Investment Portfolios Ii Llc (see advisory)
2017-12-28 N-Q Target Portfolio Trust (see advisory)
2018-02-28 N-Q Wells Fargo Funds Trust (see advisory)
2017-10-30 N-Q Delaware Group Global & International Funds (see advisory)
2017-12-28 N-Q Putnam Funds Trust (see advisory)
2017-09-29 N-Q Global X Funds (see advisory)
2017-09-28 N-Q Fidelity Advisor Series I (see advisory)
2018-01-26 N-Q VANGUARD WORLD FUND (see advisory)
2017-09-26 N-Q Legg Mason Etf Investment Trust (see advisory)
2017-11-29 N-Q Advanced Series Trust (see advisory)
2018-01-26 N-Q Templeton Growth Fund Inc (see advisory)
2018-02-28 N-Q Virtus Opportunities Trust (see advisory)
2017-09-28 N-Q Old Westbury Funds Inc (see advisory)
2018-02-28 N-Q Pacific Funds Series Trust (see advisory)
2018-01-26 N-Q Legg Mason Partners Institutional Trust (see advisory)
2018-02-27 N-Q Putnam Asset Allocation Funds (see advisory)
2017-09-28 N-Q Vanguard Star Funds (see advisory)
2017-12-26 N-Q Deutsche Portfolio Trust (see advisory)
2017-12-26 N-Q Deutsche Money Funds (see advisory)
2018-01-26 N-Q Jpmorgan Trust I (see advisory)
2018-02-27 N-Q Massmutual Select Funds (see advisory)
2017-11-29 N-Q Lord Abbett Series Fund Inc (see advisory)
2017-12-29 N-Q Oppenheimer Government Money Market Fund (see advisory)
2017-11-22 N-Q Blackrock Index Funds, Inc. (see advisory)
2018-02-23 N-Q Sterling Capital Funds (see advisory)
2017-11-28 N-Q Cohen & Steers Reit & Preferred Income Fund Inc (see advisory)
2018-02-26 N-Q Western Asset High Income Opportunity Fund Inc. (see advisory)
2018-03-01 N-Q Oppenheimer International Bond Fund (see advisory)
2017-12-29 N-Q Oppenheimer Corporate Bond Fund (see advisory)
2017-09-20 N-Q Dreyfus Opportunity Funds (see advisory)
2018-02-23 N-Q Western Asset Variable Rate Strategic Fund Inc. (see advisory)
2018-02-26 N-Q Master Large Cap Series Llc (see advisory)
2018-01-29 N-Q First American Funds Inc (see advisory)
2018-01-26 N-Q Master Portfolio Trust (see advisory)
2017-12-29 N-Q Nuveen Preferred & Income Opportunities Fund (see advisory)
2018-03-01 N-Q Spdr Index Shares Funds (formerly Streettracks Index Shares Funds) (see advisory)
2017-10-30 N-Q John Hancock Bond Trust (see advisory)
2017-11-28 N-Q Cohen & Steers Quality Income Realty Fund Inc (see advisory)
2017-11-28 N-Q Pacific Select Fund (see advisory)
2017-11-24 N-Q Alight Series Trust (see advisory)
2017-09-20 N-Q Dreyfus Index Funds Inc (see advisory)
2017-12-21 N-Q American Pension Investors Trust (see advisory)
2017-09-27 N-Q American Century International Bond Funds (see advisory)
2017-11-29 N-Q Lord Abbett Bond Debenture Fund Inc (see advisory)
2017-09-28 N-Q Powershares Exchange-traded Fund Trust Ii (see advisory)
2017-10-25 N-Q Western Asset Global High Income Fund Inc. (see advisory)
2018-03-01 N-Q Nuveen Investment Trust V (see advisory)
2017-11-22 N-Q Western Asset Premier Bond Fund (see advisory)
2017-11-28 N-Q Templeton Global Investment Trust (see advisory)
2017-12-29 N-Q Nuveen Preferred & Income Securities Fund (see advisory)
2017-09-28 N-Q Prudential Investment Portfolios 2 (see advisory)
2017-09-26 N-Q Transamerica Funds (see advisory)
2018-02-27 N-Q Bernstein Sanford C Fund Inc (see advisory)
2018-02-23 N-Q Destra Investment Trust (see advisory)
2017-11-22 N-Q Quantitative Master Series Llc (see advisory)
2017-12-29 N-Q Nuveen Preferred & Income Term Fund (see advisory)
2017-09-29 N-Q Global Income Builder Portfolio (see advisory)
2018-01-26 N-Q Sei Catholic Values Trust (see advisory)
2017-10-30 N-Q Oppenheimer Global Multi Strategies Fund (see advisory)
2017-09-20 N-Q Dreyfus Bny Mellon Funds, Inc. (see advisory)
2018-02-28 N-Q Seasons Series Trust (see advisory)
2018-03-01 N-Q Janus Investment Fund (see advisory)
2017-12-28 N-Q George Putnam Balanced Fund (see advisory)
2017-11-29 N-Q Templeton Institutional Funds (see advisory)
2018-01-29 N-Q Goldman Sachs Etf Trust (see advisory)
2018-02-28 N-Q Fidelity Central Investment Portfolios Llc (see advisory)
2017-11-28 N-Q Fidelity School Street Trust (see advisory)
2017-09-29 N-Q Eaton Vance Tax Advantaged Global Dividend Income Fund (see advisory)
2018-01-29 N-Q Oppenheimer Limited-term Bond Fund (see advisory)
2018-03-01 N-Q Aqr Funds (see advisory)
2018-02-28 N-Q Deutsche Income Trust (see advisory)
2017-11-22 N-Q Mml Series Investment Fund (see advisory)
2017-11-29 N-Q Clayton Street Trust (see advisory)
2017-11-28 N-Q Active Assets Prime Trust (see advisory)
2017-11-29 N-Q Deutsche Variable Series I (see advisory)
2017-11-28 N-Q Templeton Global Opportunities Trust (see advisory)
2017-11-28 N-Q Jnl Investors Series Trust (see advisory)
2017-12-27 N-Q Advisors' Inner Circle Fund Ii (see advisory)
2017-09-28 N-Q Vanguard International Equity Index Funds (see advisory)
2017-11-29 N-Q Oppenheimer Integrity Funds (see advisory)
2018-02-26 N-Q Bernstein Sanford C Fund Ii Inc (see advisory)
2018-03-08 N-Q Calamos Investment Trust/il (see advisory)
2017-09-25 N-Q Western Asset Global Corporate Defined Opportunity Fund Inc. (see advisory)
2017-09-27 N-Q Master Institutional Money Market Llc (see advisory)
2017-11-27 N-Q Goldman Sachs Variable Insurance Trust (see advisory)
2018-02-26 N-Q Alliancebernstein Global High Income Fund Inc (see advisory)
2017-11-29 N-Q Nuveen Global High Income Fund (see advisory)
2017-09-26 N-Q Morgan Stanley Institutional Liquidity Funds (see advisory)
2017-09-22 N-Q Cohen & Steers Low Duration Preferred & Income Fund, Inc. (see advisory)
2018-02-28 N-Q Sunamerica Income Funds (see advisory)
2017-10-27 N-Q Western Asset High Yield Defined Opportunity Fund Inc. (see advisory)
2018-02-28 N-Q Gps Funds I (see advisory)
2017-09-29 N-Q Eaton Vance Nextshares Trust (see advisory)
2018-03-08 N-Q Calamos Global Dynamic Income Fund (see advisory)
2017-10-27 N-Q Trust For Professional Managers (see advisory)
2017-10-30 N-Q John Hancock Sovereign Bond Fund (see advisory)
2017-09-28 N-Q Fidelity Salem Street Trust (see advisory)
2018-02-26 N-Q Master Bond Llc (see advisory)
2017-11-29 N-Q Blackrock Series Fund, Inc. (see advisory)
2017-09-20 N-Q Citizensselect Funds (see advisory)
2017-11-28 N-Q Cohen & Steers Infrastructure Fund Inc (see advisory)
2017-11-29 N-Q Oppenheimer Variable Account Funds (see advisory)
2017-10-30 N-Q Northern Lights Fund Trust Iv (see advisory)
2018-02-26 N-Q Blackrock Balanced Capital Fund, Inc. (see advisory)
2017-09-27 N-Q Ab High Income Fund Inc (see advisory)
2017-11-28 N-Q Universal Institutional Funds Inc (see advisory)
2017-11-27 N-Q Lazard Funds Inc (see advisory)
2018-01-26 N-Q J.p. Morgan Exchange-traded Fund Trust (see advisory)
2018-03-01 N-Q Sei Institutional International Trust (see advisory)
2017-11-24 N-Q Mfs Variable Insurance Trust Iii (see advisory)
2018-01-26 N-Q Fidelity Commonwealth Trust Ii (see advisory)
2017-10-30 N-Q Oppenheimer Institutional Government Money Market Fund (see advisory)
2018-03-01 N-Q Calvert Responsible Index Series, Inc. (see advisory)
2017-12-26 N-Q Morgan Stanley Us Government Money Market Trust (see advisory)
2017-11-28 N-Q Cohen & Steers Real Assets Fund, Inc. (see advisory)
2018-01-26 N-Q Fidelity Advisor Series Ii (see advisory)
2017-11-28 N-Q Morgan Stanley Institutional Fund Inc (see advisory)
2018-02-28 N-Q Goldman Sachs Trust (see advisory)
2017-11-28 N-Q Variable Insurance Products Fund (see advisory)
2017-11-29 N-Q Eaton Vance Tax-managed Global Buy-write Opportunities Fund (see advisory)
2017-09-29 N-Q Eaton Vance Tax-advantaged Global Dividend Opportunities Fund (see advisory)
2017-09-27 N-Q Payden & Rygel Investment Group (see advisory)
2018-02-28 N-Q Morgan Stanley Income Securities Inc (see advisory)
2017-11-21 N-Q Penn Series Funds Inc (see advisory)
2017-11-28 N-Q Western Asset Funds Inc (see advisory)
2018-01-24 N-Q Investors Cash Trust (see advisory)
2017-10-27 N-Q Valic Co I (see advisory)
2017-11-29 N-Q Baird Funds Inc (see advisory)
2017-10-30 N-Q Vanguard Wellington Fund (see advisory)
2017-11-29 N-Q Deutsche Securities Trust (see advisory)
2017-09-26 N-Q Deutsche Global/international Fund, Inc. (see advisory)
2017-12-29 N-Q Adviser Managed Trust (see advisory)
2018-02-26 N-Q Blackrock Bond Fund, Inc. (see advisory)
2018-01-24 N-Q Legg Mason Partners Money Market Trust (see advisory)
2017-09-28 N-Q Vanguard Charlotte Funds (see advisory)
2017-11-29 N-Q Amg Funds Iii (see advisory)
2018-02-28 N-Q Gps Funds Ii (see advisory)
2017-09-29 N-Q Putnam Income Fund (see advisory)
2018-02-26 N-Q Ab Global Bond Fund, Inc. (see advisory)
2018-02-28 N-Q Morgan Stanley Institutional Fund Trust (see advisory)
2018-03-01 N-Q Oppenheimer Global Strategic Income Fund (see advisory)
2018-01-26 N-Q Fidelity Puritan Trust (see advisory)
2017-11-29 N-Q Deutsche Variable Series Ii (see advisory)
2017-09-29 N-Q John Hancock Investment Trust (see advisory)
2017-11-29 N-Q Sma Relationship Trust (see advisory)
2018-03-01 N-Q Optimum Fund Trust (see advisory)
2017-11-27 N-Q Voya Balanced Portfolio Inc (see advisory)
2018-02-26 N-Q Blackrock Funds Ii (see advisory)
2017-10-27 N-Q Dbx Etf Trust (see advisory)
2017-10-27 N-Q Ab Global Risk Allocation Fund, Inc. (see advisory)
2017-09-27 N-Q Advisors' Inner Circle Fund Iii (see advisory)
2017-11-29 N-Q Deutsche Institutional Funds (see advisory)
2017-10-24 N-Q Federated Global Allocation Fund (see advisory)
2017-11-14 N-Q Russell Investment Funds (see advisory)
2017-11-28 N-Q Cohen & Steers Preferred Securities & Income Fund, Inc. (see advisory)
2017-09-25 N-Q Western Asset High Income Fund Ii Inc. (see advisory)
2018-02-28 N-Q Ishares Trust (see advisory)
2017-11-28 N-Q Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. (see advisory)
2017-09-28 N-Q Mfs Series Trust Xv (see advisory)
2017-11-28 N-Q Cohen & Steers Select Preferred & Income Fund, Inc. (see advisory)
2017-09-29 N-Q Advisorone Funds (see advisory)
2017-11-28 N-Q Legg Mason Partners Variable Income Trust (see advisory)

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.


  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( EPA:ACA / CREDIT AGRICOLE ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...